Cencora Inc
COR256.070USD
+2.070+0.81%
Cierre 03/13, 16:00(ET)Cotizaciones retrasadas 15 min
49.91BCap. mercado
35.75P/E TTM
Información de Cencora Inc Compañía
Información de la empresa
Código de la empresaCOR
Nombre de la empresaCencora Inc
Fecha de salida a bolsaMay 28, 1996
Fundada en2001
Director ejecutivoDr. Robert P. (Bob) Mauch, Ph.D.
Número de empleados42000
Tipo de títulosOrdinary Share
Fin del año fiscalMay 28
Dirección1 West First Avenue
CiudadCONSHOHOCKEN
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal19428
Teléfono16107277000
Sitio Webhttps://www.cencora.com/
Código de la empresaCOR
Fecha de salida a bolsaMay 28, 1996
Fundada en2001
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
319.91K
-0.62%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
22.10K
+3.70%
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
18.79K
+0.28%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Chief Human Resource Officer, Executive Vice President
15.37K
-24.54%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.28K
+6.86%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
2.77K
+39.81%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
957.00
+469.64%
Mr. Bennett S. Murphy
Mr. Bennett S. Murphy
Senior Vice President, Investor Relations
Senior Vice President, Investor Relations
--
--
Mr. Francois Mandeville
Mr. Francois Mandeville
Executive Vice President - Strategy and M&A
Executive Vice President - Strategy and M&A
--
--
Mr. D. Mark Durcan
Mr. D. Mark Durcan
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
319.91K
-0.62%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
22.10K
+3.70%
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
18.79K
+0.28%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Chief Human Resource Officer, Executive Vice President
15.37K
-24.54%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.28K
+6.86%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
2.77K
+39.81%
Desglose de ingresos

No datos encontrados

No datos encontrados
Por negocio
Por región

No datos encontrados
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
10.95%
Walgreens Boots Alliance Inc
6.48%
BlackRock Institutional Trust Company, N.A.
5.56%
T. Rowe Price Associates, Inc.
4.44%
State Street Global Advisors (US)
4.14%
Other
68.40%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
10.95%
Walgreens Boots Alliance Inc
6.48%
BlackRock Institutional Trust Company, N.A.
5.56%
T. Rowe Price Associates, Inc.
4.44%
State Street Global Advisors (US)
4.14%
Other
68.40%
Tipo
Accionista
Proporción
Investment Advisor
39.88%
Investment Advisor/Hedge Fund
38.05%
Corporation
6.49%
Research Firm
4.22%
Hedge Fund
3.91%
Pension Fund
2.08%
Bank and Trust
1.94%
Sovereign Wealth Fund
1.18%
Family Office
1.17%
Other
1.03%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo de informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
2149
191.86M
99.05%
-13.40M
2024Q4
2214
199.53M
103.03%
-6.12M
2024Q3
2134
200.04M
102.56%
+474.02K
2024Q2
2090
200.10M
100.34%
-7.14M
2024Q1
2068
201.37M
100.95%
-1.37M
2023Q4
1982
202.45M
101.40%
+179.00K
2023Q3
1885
197.70M
97.79%
-2.15M
2023Q2
1870
195.00M
96.41%
-1.87M
2023Q1
1823
192.69M
95.24%
-7.50M
2022Q4
1797
190.04M
93.86%
-247.07K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
21.22M
10.95%
+5.67K
+0.02%
Dec 31, 2024
Walgreens Boots Alliance Inc
19.98M
10.33%
--
--
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
10.77M
5.56%
+112.07K
+1.05%
Dec 31, 2024
T. Rowe Price Associates, Inc.
8.60M
4.44%
+71.26K
+0.83%
Dec 31, 2024
State Street Global Advisors (US)
8.03M
4.14%
-14.00K
-0.17%
Dec 31, 2024
Wellington Management Company, LLP
5.05M
2.61%
-135.52K
-2.60%
Dec 31, 2024
Boston Partners
5.00M
2.58%
+125.61K
+2.57%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.32M
2.23%
+130.21K
+3.10%
Dec 31, 2024
JP Morgan Asset Management
3.45M
1.78%
+46.78K
+1.37%
Dec 31, 2024
Capital Research Global Investors
2.89M
1.49%
+4.61K
+0.15%
Dec 31, 2024
Ver más
ETF relacionados
Hora de actualización: mié., 5 de mar
Hora de actualización: mié., 5 de mar
Nombre
Proporción
VanEck Pharmaceutical ETF
4.59%
AdvisorShares Focused Equity ETF
4.46%
Invesco Dorsey Wright Healthcare Momentum ETF
3.43%
VictoryShares US Multi-Factor Minimum Vol ETF
3.38%
VanEck Retail ETF
2.85%
First Trust Growth Strength ETF
2.43%
Amplify Cash Flow Dividend Leaders ETF
2.25%
SPDR S&P Health Care Services ETF
2.22%
Invesco S&P 500 Revenue ETF
2.09%
First Trust Consumer Staples Alphadex Fund
2.06%
Ver más
VanEck Pharmaceutical ETF
Proporción4.59%
AdvisorShares Focused Equity ETF
Proporción4.46%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción3.43%
VictoryShares US Multi-Factor Minimum Vol ETF
Proporción3.38%
VanEck Retail ETF
Proporción2.85%
First Trust Growth Strength ETF
Proporción2.43%
Amplify Cash Flow Dividend Leaders ETF
Proporción2.25%
SPDR S&P Health Care Services ETF
Proporción2.22%
Invesco S&P 500 Revenue ETF
Proporción2.09%
First Trust Consumer Staples Alphadex Fund
Proporción2.06%
Dividendos
Un total de
1.91B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Nov 02, 2023
COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023
Nov 13, 2023
Nov 27, 2023
Nov 10, 2023
Aug 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023
Aug 11, 2023
Aug 28, 2023
Aug 10, 2023
May 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on May 30, 2023 going ex on May 11, 2023
May 12, 2023
May 30, 2023
May 11, 2023
Feb 01, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Feb 27, 2023 going ex on Feb 09, 2023
Feb 10, 2023
Feb 27, 2023
Feb 09, 2023
Nov 04, 2022
COR.NB Final Cash Dividend of gross USD 0.485 paid on Nov 28, 2022 going ex on Nov 10, 2022
Nov 14, 2022
Nov 28, 2022
Nov 10, 2022
Ver más
División de acciones
Fecha
Tipo
Relación

No datos encontrados
Fecha
Tipo
Relación

No datos encontrados